Evgenia Glogova
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 3
-
- Acute Lymphoblastic Leukemia research 10
-
- Neuroblastoma Research and Treatments 6
-
- Childhood Cancer Survivors' Quality of Life 6
-
- Cancer, Hypoxia, and Metabolism 3
-
- Cancer therapeutics and mechanisms 3
In The Last Decade
Evgenia Glogova
21 papers receiving 272 citations
Peers
Comparison fields: 5 of 49
- Hematology 166
- Public Health, Environmental and Occupational Health 87
- Neurology 40
- Immunology 55
- Transplantation 7
Countries citing papers authored by Evgenia Glogova
This map shows the geographic impact of Evgenia Glogova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evgenia Glogova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evgenia Glogova more than expected).
Fields of papers citing papers by Evgenia Glogova
This network shows the impact of papers produced by Evgenia Glogova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evgenia Glogova. The network helps show where Evgenia Glogova may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Evgenia Glogova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 2 | |
| 5 | 2020 | 9 | |
| 6 | 2019 | 25 | |
| 7 | 2018 | 20 | |
| 8 | 2017 | 9 | |
| 9 | 2016 | 4 | |
| 10 | 2016 | 17 | |
| 11 | 2016 | 13 | |
| 12 | 2015 | 56 | |
| 13 | 2015 | 26 | |
| 14 | 2015 | 1 | |
| 15 | THE ROLE OF MEGATHERAPY (MGT) AND STEM CELL TRANSPLANTATION (SCT) IN HIGH RISK EWING TUMORS (ET): MORE THAN 30 YEARS OF EBMT ACTIVITY | 2014 | 1 |
| 16 | 2014 | 4 | |
| 17 | 2014 | 7 | |
| 18 | 2014 | 30 | |
| 19 | Modeling Dependent Credit Risks for Application to Off-Site Banking Supervision | 2006 | 1 |
| 20 | Determinants of Initial Public Offerings - A European Time-Series Cross-Section Analysis | 2002 | 12 |
About Evgenia Glogova
Evgenia Glogova is a scholar working on Hematology, Neurology and Transplantation, having authored 24 papers that have together received 278 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Acute Lymphoblastic Leukemia research (10 papers), Childhood Cancer Survivors' Quality of Life (6 papers), Neuroblastoma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Hematology (166 citations), Public Health, Environmental and Occupational Health (87 citations) and Neurology (40 citations). Evgenia Glogova has collaborated with scholars based in Austria, Italy and Germany. Frequent co-authors include Ulrike Pötschger, Christina Peters, Heidrun Boztug, Paul Veys, Isaac Yaniv, Jacek Wachowiak, Petr Sedláček, Arjan C. Lankester, Mary Slatter and Ulrike Pöetschger. Their work appears in journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.